ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Agouron Pharmaceuticals


Include trials that are no longer recruiting patients.

19 studies were found.
1.No longer recruitingChemotherapy in Treating Patients Who Have Metastatic Prostate Cancer
Condition: stage IV prostate cancer
2.CompletedCombination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy
Condition: HIV Infections
3.SuspendedEffectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients
Condition: HIV Infections
4.RecruitingEffectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected with HIV
Condition: HIV Infections
5.No longer recruitingEffectiveness of Treating HIV-Positive Patients with an HIV Vaccine (Remune)
Condition: HIV Infections
6.CompletedPhase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants
Condition: HIV Infections
7.CompletedA Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients with CD4 <= 500 cells/mm3
Conditions: Sarcoma, Kaposi; HIV Infections
8.No longer recruitingPrinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer
Conditions: Quality of Life; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
9.No longer recruitingPrinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: adult glioblastoma multiforme; Quality of Life
10.TerminatedSafety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir
Condition: HIV Infections
11.SuspendedSafety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
Condition: HIV Infections
12.CompletedSafety and Effectiveness of Treating HIV-Positive Patients with an HIV Vaccine (Remune)
Condition: HIV Infections
13.CompletedA Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments
Condition: HIV Infections
14.CompletedA Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis
Conditions: Cytomegalovirus Retinitis; HIV Infections
15.CompletedA Study of Viracept in AIDS Patients with Mycobacterium Avium Complex Disease (MAC)
Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections
16.CompletedA Study of Viracept in HIV-Positive Women
Condition: HIV Infections
17.CompletedA Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors
Condition: HIV Infections
18.No longer recruitingTreatment with Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
Condition: HIV Infections
19.CompletedViracept Expanded Access Program
Condition: HIV Infections

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act